Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

2018 
Introduction Rituximab is considered as a potential therapeutic option in relapsing-remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS).
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    25
    References
    28
    Citations
    NaN
    KQI
    []